264 related articles for article (PubMed ID: 18640142)
1. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
[TBL] [Abstract][Full Text] [Related]
2. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
3. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
[TBL] [Abstract][Full Text] [Related]
4. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
5. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Huang CY; Hsueh YM
Sci Total Environ; 2011 Jan; 409(3):465-70. PubMed ID: 21094982
[TBL] [Abstract][Full Text] [Related]
7. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
8. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
10. Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
Urol Int; 2008; 80(4):405-12. PubMed ID: 18587252
[TBL] [Abstract][Full Text] [Related]
11. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
[TBL] [Abstract][Full Text] [Related]
12. Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer.
Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Detect Prev; 2007; 31(3):225-32. PubMed ID: 17561354
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
[TBL] [Abstract][Full Text] [Related]
14. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
16. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer.
Chung CJ; Hsueh YM; Bai CH; Huang YK; Huang YL; Yang MH; Chen CJ
Cancer Causes Control; 2009 Nov; 20(9):1653-61. PubMed ID: 19680750
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
Chung CJ; Pu YS; Su CT; Chen HW; Huang YK; Shiue HS; Hsueh YM
Cancer Causes Control; 2010 Oct; 21(10):1605-13. PubMed ID: 20532609
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma.
Huang CY; Pu YS; Shiue HS; Chen WJ; Lin YC; Hsueh YM
Arch Toxicol; 2016 Aug; 90(8):1917-27. PubMed ID: 26359225
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
